$98.92
6.34% yesterday
Nasdaq, Nov 03, 10:00 pm CET
ISIN
US40131M1099
Symbol
GH

Guardant Health, Inc. Stock price

$98.92
+36.08 57.42% 1M
+54.87 124.56% 6M
+68.37 223.80% YTD
+75.32 319.15% 1Y
+53.87 119.58% 3Y
-8.77 8.14% 5Y
+66.72 207.21% 10Y
+66.72 207.21% 20Y
Nasdaq, Closing price Mon, Nov 03 2025
+5.90 6.34%

New AI Insights on Guardant Health, Inc. Insights AI Insights on Guardant Health, Inc.

How does the company make money?

Key metrics

Basic
Market capitalization
$12.5b
Enterprise Value
$13.0b
Net debt
$486.4m
Cash
$629.1m
Shares outstanding
124.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
15.0 | 13.1
EV/Sales
15.6 | 13.7
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-9.4%
Return on Equity
312.5%
ROCE
-42.1%
ROIC
-76.5%
Debt/Equity
-3.7
Financials (TTM | estimate)
Revenue
$828.9m | $948.1m
EBITDA
$-419.1m | $-226.7m
EBIT
$-460.7m | $-389.1m
Net Income
$-413.8m | $-394.8m
Free Cash Flow
$-272.0m
Growth (TTM | estimate)
Revenue
28.8% | 28.3%
EBITDA
12.0% | 43.5%
EBIT
11.2% | 12.3%
Net Income
15.7% | 9.5%
Free Cash Flow
9.0%
Margin (TTM | estimate)
Gross
62.8%
EBITDA
-50.6% | -23.9%
EBIT
-55.6%
Net
-49.9% | -41.6%
Free Cash Flow
-32.8%
More
EPS
$-3.4
FCF per Share
$-2.2
Short interest
7.0%
Employees
2k
Rev per Employee
$370.0k
Show more

Is Guardant Health, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,031 stocks worldwide.

Guardant Health, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

33 Analysts have issued a Guardant Health, Inc. forecast:

30x Buy
91%
3x Hold
9%

Analyst Opinions

33 Analysts have issued a Guardant Health, Inc. forecast:

Buy
91%
Hold
9%

Financial data from Guardant Health, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
829 829
29% 29%
100%
- Direct Costs 308 308
20% 20%
37%
521 521
35% 35%
63%
- Selling and Administrative Expenses 625 625
35% 35%
75%
- Research and Development Expense 357 357
2% 2%
43%
-419 -419
12% 12%
-51%
- Depreciation and Amortization 42 42
3% 3%
5%
EBIT (Operating Income) EBIT -461 -461
11% 11%
-56%
Net Profit -414 -414
16% 16%
-50%

In millions USD.

Don't miss a Thing! We will send you all news about Guardant Health, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Guardant Health, Inc. Stock News

Positive
Seeking Alpha
4 days ago
Guardant Health, Inc.'s Shield ADLT reimbursement, Quest, and guidance raise show good adoption momentum. These positives keep me bullish on GH stock. Their oncology business remains the revenue anchor. Biopharma & Data also came in with good margins and provided some diversification. GH's recent Q3 report showed growing revenues, more Shield tests, and, ex-Screening, they became cash flow posi...
Positive
The Motley Fool
4 days ago
The cancer-focused biotech surprised on the upside for both revenue and profitability in its latest reported quarter. Revenue rose by almost 40% year over year in that period.
Positive
Seeking Alpha
5 days ago
Guardant Health delivered extremely robust Q3 results and raised full-year guidance, with Reveal and Shield beginning to make material contributions. Guardant's therapy selection and biopharma businesses also remain strong. While GH is burning cash, this is in support of the screening business' rapid expansion. The company is now on a clear path to breakeven in the next few years.
More Guardant Health, Inc. News

Company Profile

Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Redwood City, CA.

Head office United States
CEO Helmy Eltoukhy
Employees 2,010
Founded 2012
Website guardanthealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today